Patients with severe Alzheimer's disease experienced remarkable improvements in both behavior and cognition within days of receiving low-dose radiation treatment.
Glioblastoma brain cancer cells that are more resistant to radiation therapy have higher levels of purines. Reducing the level of purines made the cancer cells more sensitive to radiation.
Trifluoperazine, a dopamine receptor antagonist commonly prescribed for schizophrenia, used in combination with radiation therapy delays the growth of glioblastoma brain tumors and prolongs survival for brain cancer.
Researchers report improved survival rates in people who received chemotherapy postoperatively for medulloblastoma brain cancer.
Researchers discover reduced gray matter volume and enlarged ventricular spaces in the brains of glioblastoma patients who have undergone chemoradiation therapies. The brain changes appear early and are progressive.
